Shorts

Dr Wang on Managing Post-CAR T Infections: Act Fast and Coordinate Care

Why Children Are Not Just ‘Little Adults’ in Cancer Treatment

Dr Wang: Check IgG Early to Prevent Infections After CAR T

Closing the Gap Between Immunotherapy Innovation and Outdated Evaluation Standards

Dr Thaker Highlights Personalized PARP Strategies and the Promise of IMNN-001 in Ovarian Cancer

Giving Patients the Power to Choose

ROSELLA Shows Survival Benefit With Convenient Relacorilant Dosing

BTK Degraders: A New Hope for Resistant CLL

A New Alternative to Phlebotomy

Promising Responses in Ewing Sarcoma Trial

Why Residual Cancer Burden is a Game-Changer for Oncology

Treating High-Risk CLL: Balancing Efficacy and Duration

Why BRAF Testing Is Critical in ATC

Rare but Targetable: Advances in Biliary Tract Cancer

The Sequencing Dilemma in Thyroid Cancer

Future-Proofing Treatment in Younger Patients With CLL

Tackling Resistance in Pancreatic Cancer

Patient Preference: The Heart of CLL Treatment Decisions

Why Every Thyroid Cancer Patient Needs Genomic Analysis

What is the Role of PCI in LS-SCLC?

Combining KRAS Inhibition With Immunotherapy in NSCLC

Evolving Clinical Utility of ctDNA in Upper GI Cancer Care

Dr Raj Singh on Advances in Head and Neck Cancer Therapy

Unlocking the Secrets of Breast Cancer Mutations

The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs

The Danger of Relying Solely on Negative ctDNA Tests

Can Myeloma Treatment Be Done at Home?

MRD Alerts: How Soon Will Imaging Confirm Progression?

The Future of Targeted Therapy in Mesothelioma

Dr Kittai on The Role of MRD Testing in CLL